The study conducted by Sun et al. investigated the impact of TRIM29 on the inhibition of cancer stem cell-like properties in pancreatic ductal adenocarcinomas, providing valuable insights into future therapeutic strategies for this very aggressive form of cancer [9]. The gene discussed is TRIM29; the disease is cancer.